News

ALSAC Celebrates Five Years as a Champion for Innovators

ALSAC Celebrates Five Years as a Champion for Innovators

ALSAC Marks Five Years on Fast Company’s Innovators List

ALSAC—the fundraising and awareness organization for St. Jude Children’s Research Hospital—has again been named to Fast Company’s 2024 Best Workplaces for Innovators list. This year’s nod makes five in a row, a streak that began in 2020 and underscores a sustained, organization-wide commitment to new ideas put to work for a clear purpose.

What This Recognition Reflects

Fast Company reviewed nearly a thousand organizations across industries and borders to identify the top 100 workplaces where creativity isn’t just encouraged but expected. ALSAC earned the #12 ranking and received recognition in the General Excellence category, which highlights workplaces that build conditions where innovation can take root, grow, and show results.

Recognizing Team Efforts

“We are honored to be recognized as a global leader in fostering innovation,” commented Richard C. Shadyac Jr., President and CEO of ALSAC. “This award reflects the hard work of our more than 1,600 team members who are dedicated to innovating for a greater purpose. Our relentless drive for new solutions enables St. Jude to support the 400,000 children who battle cancer worldwide each year.”

Innovation With a Mission

ALSAC’s push to innovate is inseparable from its mission: to help St. Jude cure childhood cancer and confront other life-threatening diseases around the world. In 2018, as St. Jude launched a global initiative to improve treatments and cures for children, ALSAC moved in lockstep—building collaborations with foundations positioned to advance that effort and extending the reach of its support beyond borders.

Global Outreach and Support

Today, ALSAC provides training and guidance to more than 130 nonprofit organizations in 64 countries. Much of this work takes place in low- and middle-income regions, where cure rates lag and resources are often stretched thin. “In keeping with our spirit of innovation and our foundational principles of inclusion, we partner with others to understand their needs, develop unique solutions, and share knowledge and resources to empower them,” Shadyac elaborated.

How ALSAC Cultivates New Ideas

Inside ALSAC, creativity isn’t reserved for a single department or job title. Employees at every level are invited to propose, test, and refine new approaches. The organization runs innovation challenges and hackathons, and it opens doors through internships that give rising talent space to experiment. These programs generate fresh solutions to real problems and help keep a culture of innovation alive and moving.

The Impact of Open Discussion

“Children’s lives depend on our ability to foster open dialogue and innovative problem-solving,” Shadyac stated. “We ensure that every team member understands that innovation is not just a priority; it is something to be nurtured, appreciated, and celebrated.”

Join ALSAC's Visionary Team

If you’re drawn to work that pairs bold thinking with measurable impact, ALSAC invites you to be part of its mission-driven team. Every role supports St. Jude and its guiding mantra: Finding cures. Saving children. Whether you bring technical skills, creative insight, or on-the-ground experience, there’s room to contribute.

About St. Jude Children’s Research Hospital

St. Jude Children’s Research Hospital is dedicated to understanding, treating, and ultimately defeating childhood cancer and other life-threatening diseases. Its mission is clear and constant: Finding cures. Saving children. As the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children, St. Jude has led advances in pediatric care since 1962. At that time, childhood cancer was largely considered incurable. Today, through unrelenting research and treatment progress, the overall survival rate has risen from 20% to over 80%. The goal remains urgent and simple: ensure no child dies from cancer.

St. Jude freely shares discoveries with local hospitals and cancer centers worldwide so that children, regardless of where they live, can benefit from the latest insights. Families never receive a bill from St. Jude for treatment, travel, housing, or food, allowing them to focus entirely on their child’s care. For real stories of determination and progress, visit St. Jude Inspire. To support the mission, consider donating at stjude.org.

Frequently Asked Questions

What is ALSAC, and how does it support St. Jude?

ALSAC stands for the American Lebanese Syrian Associated Charities. It serves as the fundraising and awareness organization for St. Jude Children’s Research Hospital, rallying resources and support so St. Jude can focus on research and treatment for childhood cancer and other life-threatening diseases.

What does Fast Company’s 2024 recognition say about ALSAC?

Fast Company named ALSAC to its 2024 Best Workplaces for Innovators list, ranking it #12 and honoring it in the General Excellence category. It’s the fifth consecutive year—since 2020—that ALSAC has earned a place on the list, signaling a durable culture that nurtures ideas and turns them into action.

How is ALSAC driving global impact through innovation?

Aligned with St. Jude’s 2018 global initiative, ALSAC collaborates with foundations and supports more than 130 nonprofit organizations in 64 countries. Much of this work focuses on low- and middle-income regions, pairing training, guidance, and shared knowledge with local needs to help improve access to treatment and strengthen outcomes.

How does ALSAC encourage employees to innovate day to day?

ALSAC creates space for experimentation at every level, from innovation challenges and hackathons to internships that cultivate emerging talent. Leaders champion open dialogue and make it clear that new ideas should be nurtured, appreciated, and celebrated—because better ideas can lead to better solutions for children and families.

How can I get involved with ALSAC and support St. Jude?

You can explore career opportunities at ALSAC, participate in community fundraising, or donate directly. St. Jude shares its stories through St. Jude Inspire, and gifts can be made at stjude.org—each action helping sustain the mission of Finding cures. Saving children.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Microfluidics Market Growth: Insights and Future Trends

Updated Category News Views 112

Microfluidics Market Overview The global microfluidics market, valued at approximately USD 21.36 billion, is set for impressive growth. Predictions suggest it will reach about USD 32.67 billion by the end of 2029. This significant expansion is a clear indicator of the transformation occurring within diagnostics, life sciences, and pharmaceutical research. Driving Forces...

Continue Reading
How a $1000 Investment in Primerica Can Grow Over Time

Updated Category News Views 333

The Incredible Growth of Primerica Primerica (NYSE: PRI) has truly left a mark in the financial sector, showcasing remarkable performance over the last decade. With an annualized return of 17.97%, it has outperformed the market by 7.08%, demonstrating its strong foundational growth and investment appeal. As of now, Primerica holds a market capitalization of $9.18 billion,...

Continue Reading
Illumina Joins Forces with MyOme: A Game Changer in Healthcare

Updated Category News Views 115

Illumina and MyOme Collaboration Overview Illumina has recently entered into a significant collaboration deal with MyOme, a company specializing in genomic analysis. This partnership isn't just a strategic investment; it's an aerospace-like synergy aimed at transforming how healthcare operates in the United States. With a bold vision, the duo is set to explore innovative...

Continue Reading
BlackSky Technology Secures Major Contract Boosting Stock Appeal

Updated Category News Views 117

BlackSky Technology Gains Momentum After Major Contract Win BlackSky Technology Inc (BKSY) has seen its shares trade higher recently thanks to the remarkable announcement of a five-year contract with the U.S. National Geospatial-Intelligence Agency (NGA). This contract, valued at up to $290 million, will enable BlackSky to leverage its advanced satellite monitoring...

Continue Reading
BioXcel Therapeutics to Showcase Innovations at Conference

Updated Category News Views 255

BioXcel Therapeutics: AI in Medicine BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is making waves in the biopharmaceutical sector using artificial intelligence (AI) to forge new paths in neuroscience medication. The CEO, Vimal Mehta, Ph.D., will take the stage at the highly regarded Canaccord Genuity 45th Annual Growth Conference. This pivotal event will take place in...

Continue Reading